NL7907609A - Cyclosporinederivaten en werkwijzen voor het bereiden en toepassen van deze derivaten. - Google Patents

Cyclosporinederivaten en werkwijzen voor het bereiden en toepassen van deze derivaten. Download PDF

Info

Publication number
NL7907609A
NL7907609A NL7907609A NL7907609A NL7907609A NL 7907609 A NL7907609 A NL 7907609A NL 7907609 A NL7907609 A NL 7907609A NL 7907609 A NL7907609 A NL 7907609A NL 7907609 A NL7907609 A NL 7907609A
Authority
NL
Netherlands
Prior art keywords
cyclosporin
preparing
derivatives
isocyclosporin
dihydrocyclosporin
Prior art date
Application number
NL7907609A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1077678A external-priority patent/CH637124A5/de
Priority claimed from CH269679A external-priority patent/CH639961A5/de
Priority claimed from CH748079A external-priority patent/CH642954A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL7907609A publication Critical patent/NL7907609A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/885—Trichoderma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NL7907609A 1978-10-18 1979-10-15 Cyclosporinederivaten en werkwijzen voor het bereiden en toepassen van deze derivaten. NL7907609A (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CH1077678A CH637124A5 (en) 1978-10-18 1978-10-18 Antibiotic, its preparation and use
CH1077678 1978-10-18
CH269679A CH639961A5 (en) 1979-03-22 1979-03-22 Dihydocyclosporin G, its preparation and use as a medicine
CH269679 1979-03-22
CH748079A CH642954A5 (en) 1979-08-15 1979-08-15 Isocyclosporin G, its preparation and medicaments containing it
CH748079 1979-08-15

Publications (1)

Publication Number Publication Date
NL7907609A true NL7907609A (nl) 1980-04-22

Family

ID=27173855

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7907609A NL7907609A (nl) 1978-10-18 1979-10-15 Cyclosporinederivaten en werkwijzen voor het bereiden en toepassen van deze derivaten.

Country Status (22)

Country Link
US (1) US4288431A (sv)
AU (1) AU530379B2 (sv)
CA (1) CA1129359A (sv)
CY (1) CY1286A (sv)
DE (1) DE2941080A1 (sv)
DK (1) DK148752C (sv)
ES (1) ES485104A1 (sv)
FI (1) FI60032C (sv)
FR (1) FR2439182A1 (sv)
GB (1) GB2033398B (sv)
HK (1) HK48685A (sv)
IE (1) IE49084B1 (sv)
IL (1) IL58465A (sv)
IT (1) IT1164109B (sv)
KE (1) KE3517A (sv)
MY (1) MY8500618A (sv)
NL (1) NL7907609A (sv)
NZ (1) NZ191865A (sv)
PH (1) PH14086A (sv)
PT (1) PT70324A (sv)
SE (1) SE448386B (sv)
SG (1) SG14685G (sv)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4396542A (en) * 1980-02-14 1983-08-02 Sandoz Ltd. Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
EP0098457B1 (en) * 1980-02-14 1987-08-05 Sandoz Ag (1s,2r,3r)- and (1r,2s,3s)-nitrilo-1-carbonyl-3-methyl-2-oxy-heptanes and -hept-5-enes useful in the total synthesis of cyclosporins and processes for their production
EP0056782B1 (en) * 1981-01-09 1984-08-01 Sandoz Ag Novel cyclosporins
EP0365044A3 (en) * 1984-08-02 1990-08-22 Sandoz Ag Novel pharmaceutical use of (nva)2-cyclosporine
GB8422253D0 (en) * 1984-09-04 1984-10-10 Sandoz Ltd Organic compounds
US4727035A (en) * 1984-11-14 1988-02-23 Mahoney Walter C Immunoassay for cyclosporin
US4814323A (en) * 1986-03-25 1989-03-21 Andrieu J M Process for the treatment and the prevention of AIDS and other disorders induced by the LAV/HTLV III virus
US5427960A (en) * 1987-03-27 1995-06-27 Abbott Laboratories Fluorescence polarization assay for cyclosporin A and metabolites and related immunogens and antibodies
US5239057A (en) * 1987-03-27 1993-08-24 Abbott Laboratories Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
DE3888357T2 (de) * 1987-06-22 1994-09-15 Merck & Co Inc Cyclosporin-Derivate, die eine modifizierte Aminosäure auf Stellung 8 tragen.
GB8717300D0 (en) * 1987-07-22 1987-08-26 Nat Res Dev Cyclosporins
US5227467A (en) * 1987-08-03 1993-07-13 Merck & Co., Inc. Immunosuppressive fluorinated cyclosporin analogs
WO1989001772A1 (en) * 1987-09-03 1989-03-09 University Of Georgia Research Foundation, Inc. Ocular cyclosporin composition
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
US5236899A (en) * 1987-11-16 1993-08-17 Merck & Co., Inc. 6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance
US4914188A (en) * 1987-11-16 1990-04-03 Merck & Co., Inc. Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
HU201577B (en) * 1988-12-20 1990-11-28 Gyogyszerkutato Intezet Process for producing cyclosporin antibiotics
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
FR2649120B1 (fr) * 1989-06-30 1994-01-28 Cayla Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US5122511A (en) * 1990-02-27 1992-06-16 Merck & Co., Inc. Immunosuppressive cyclosporin analogs with modified amino acids at position-8
ES2078374T3 (es) * 1991-04-06 1995-12-16 Dresden Arzneimittel Procedimiento para la produccion por fermentacion y aislamiento de ciclosporina a, y nuevas cepas formadoras de ciclosporina.
BR9205967A (pt) * 1991-05-03 1994-07-26 Seragen Inc Moléculas marcadas com receptor de interleucina tratamento de artrite inflamatória
GB9203886D0 (en) * 1992-02-24 1992-04-08 Sandoz Ltd Improvements in or relating to organic compounds
ES2065273B1 (es) * 1993-05-25 1995-09-16 Biogal Gyogyszergyar Procedimiento para la purificacion de ciclosporina a.
DE19611094C2 (de) 1996-03-21 1999-06-17 Dresden Arzneimittel Verfahren zur Reinigung von Cyclosporin A und/oder verwandten Cyclosporinen aus einem Cyclosporin-haltigen Rohextrakt unter Anwendung chromatographischer Verfahren mit Kieselgel als Adsorbens
US5747330A (en) * 1996-06-05 1998-05-05 Poli Industria Chimica Antibiotic producing microbe
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
NZ502362A (en) 1997-10-08 2001-05-25 Isotechnika Inc Deuterated cyclosporine A derivatives and their use as immunomodulating agents
ATE312843T1 (de) 1998-07-01 2005-12-15 Debiopharm Sa Neues cyclosporin mit verbesserter wirkung
ATE306558T1 (de) * 2000-02-29 2005-10-15 Biocon Ltd Herstellung und reinigung von cyclosporin-a
EP1406700A1 (en) 2001-07-06 2004-04-14 Sucampo AG Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent
WO2003033526A2 (en) * 2001-10-19 2003-04-24 Isotechnika Inc. Synthesis of cyclosporin analogs
EP1458405A1 (en) * 2001-11-21 2004-09-22 Sucampo AG Use of fk506 and analogues for treating allergic diseases
AU2004222306A1 (en) * 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
US7378391B2 (en) * 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
JP2008514702A (ja) * 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド 新規シクロスポリン類似体およびそれらの薬学的使用
JP2008515886A (ja) * 2004-10-06 2008-05-15 エーエムアール テクノロジー インコーポレイテッド シクロスポリンアルキンおよびそれらの医用薬剤としての有用性
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
WO2008036244A1 (en) * 2006-09-18 2008-03-27 The Burham Institute For Medical Research Use of cyclosporin a to sensitize resistant cancer cells to death receptor ligands
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
EP2391376A4 (en) * 2009-01-30 2012-08-01 Enanta Pharm Inc ANALOGUES OF CYCLOSPORIN FOR PREVENTING OR TREATING HEPATITIS C INFECTION
US8481483B2 (en) * 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8367053B2 (en) * 2009-07-09 2013-02-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8685917B2 (en) * 2009-07-09 2014-04-01 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8349312B2 (en) * 2009-07-09 2013-01-08 Enanta Pharmaceuticals, Inc. Proline substituted cyclosporin analogues
US8623814B2 (en) * 2010-02-23 2014-01-07 Enanta Pharmaceuticals, Inc. Antiviral agents
AU2011342284C1 (en) 2010-12-15 2017-07-13 Contravir Pharmaceuticals, Inc. Cyclosporine analogue molecules modified at amino acid 1 and 3
WO2012145426A1 (en) 2011-04-18 2012-10-26 The Trustees Of Columbia University In The City Of New York Methods to treat cancer using cyclosporine and cyclosporine derivatives
EP2705856A1 (en) 2012-09-07 2014-03-12 Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. Compounds for the treatment of neurodegenerative disorders
WO2014085623A1 (en) 2012-11-28 2014-06-05 Enanta Pharmaceuticals, Inc. Novel [n-me-4-hydroxyleucine]-9-cyclosporin analogues
CN105579046A (zh) 2013-08-26 2016-05-11 英安塔制药有限公司 用于预防或治疗丙型肝炎的环孢菌素类似物
US9669095B2 (en) 2014-11-03 2017-06-06 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis C infection
WO2016112321A1 (en) * 2015-01-08 2016-07-14 Allergan, Inc. Cyclosporin derivatives wherein the mebmt sidechain has been cyclized

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2463138C2 (de) * 1973-12-06 1984-07-05 Sandoz-Patent-GmbH, 7850 Lörrach Das Antibiotikum Cyclosporin B (S 7481/F-2), seine Herstellung und Verwendung
CH614931A5 (sv) * 1975-11-04 1979-12-28 Sandoz Ag
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung

Also Published As

Publication number Publication date
ES485104A1 (es) 1980-05-16
KE3517A (en) 1985-04-19
DK148752B (da) 1985-09-16
DE2941080A1 (de) 1980-05-08
AU530379B2 (en) 1983-07-14
FI793142A (fi) 1980-04-19
MY8500618A (en) 1985-12-31
AU5191179A (en) 1980-04-24
CY1286A (en) 1985-07-05
US4288431A (en) 1981-09-08
IE49084B1 (en) 1985-07-24
DK148752C (da) 1986-02-10
GB2033398A (en) 1980-05-21
DK428179A (da) 1980-04-19
FR2439182B1 (sv) 1984-02-10
FR2439182A1 (fr) 1980-05-16
GB2033398B (en) 1982-09-08
FI60032C (fi) 1981-11-10
IT7950577A0 (it) 1979-10-16
IE791967L (en) 1980-04-18
NZ191865A (en) 1984-05-31
SE7908350L (sv) 1980-04-19
FI60032B (fi) 1981-07-31
HK48685A (en) 1985-06-28
IL58465A0 (en) 1980-01-31
DE2941080C2 (sv) 1990-03-29
PH14086A (en) 1981-02-10
PT70324A (fr) 1979-11-01
CA1129359A (en) 1982-08-10
IT1164109B (it) 1987-04-08
IL58465A (en) 1982-04-30
SE448386B (sv) 1987-02-16
SG14685G (en) 1985-08-16

Similar Documents

Publication Publication Date Title
NL7907609A (nl) Cyclosporinederivaten en werkwijzen voor het bereiden en toepassen van deze derivaten.
US5502033A (en) Antimicrobial polypeptide compound a pharmaceutical composition comprising the same, and a method for treating infectious diseases
NL8500828A (nl) Cyclosporinen en werkwijzen voor het bereiden en toepassen van deze verbindingen.
CN103497238A (zh) 制备Romidepsin
JP4181632B2 (ja) 新規合成クリプトフィシン類
WO1997011092A1 (fr) Derives de phosphates de cyclosporine et composition medicinale
JPH06157594A (ja) ある種のシクロヘキサペプチドのリン酸エステル化合物の製造方法
SU867318A3 (ru) Способ получени баумицина а и в
ES2464723T3 (es) Compuesto cíclico y sal del mismo
RU2261254C2 (ru) Мемнопептиды, способ их получения и их применение
OA10400A (fr) Forme purifiée de streptogramines sa préparation et les compositions pharmaceutiques qui la contiennent
JP2779652B2 (ja) 生理活性物質ｔａｎ―１１２０，その還元体，それらの製造法および用途ならびに微生物
JPH02128693A (ja) 新規な抗腫瘍性抗生物質複合体ｂｂｍ―１６７５
EP0318254B1 (en) Tripeptide derivatives
KR820001032B1 (ko) 세스키테르펜 유도체의 제조방법
JP3913542B2 (ja) 血管新生阻害作用を有する新規物質
JPH0453867B2 (sv)
JP3502655B2 (ja) 制癌性抗生物質チアジノトリエノマイシン及びその製造法
JP3124373B2 (ja) 免疫抑制物質
FR2642762A1 (fr) Janthinomycine
JP4833461B2 (ja) 新規血管新生阻害剤
FI63743B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbart iscyklosporin
JP3875024B2 (ja) ヒト免疫不全ウイルス（ｈｉｖ）増殖を抑制する新規生理活性物質
JP2003113192A (ja) 抗生物質ｗａｐ−２６０７ｂ、その製造法及び抗菌剤
JP4870276B2 (ja) アポトーシス抑制作用を有するｒｋｂ−３３８４物質

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: NOVARTIS AG

BV The patent application has lapsed